Announce Date | 02/19/2025 |
EPS Normalized Actual | $2.66 (Beat by $0.16) |
EPS GAAP Actual | $2.66 (Beat by $0.16) |
Revenue Actual | $1.00255B |
Revenue Surprise | Beat by $1002.55M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 13.68 | 12.2 | 13.27215 | 14.58445 | 1 |
Dec 2028 | 16.97 | 9.84 | 16.64797 | 17.24229 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -4.18 | -4.18 | 1.00255B | -1.09% | 1002.55M |
FQ3 2024 (Sep 2024) | 1.34 | 1.34 | 1.00976B | -4.97% | 1009.76M |
FQ2 2024 (Jun 2024) | 1.75 | 1.75 | 1.02612B | 100% | 1026.12M |
FQ1 2024 (Mar 2024) | 1.45 | 1.45 | 1.01156B | 100% | 1011.56M |
FQ4 2023 (Dec 2023) | 0 | 0 | 1.01348B | -8.52% | 1013.48M |
FQ3 2023 (Jul 2023) | 1.89 | 1.89 | 1.05994B | 6.68% | 1059.94M |
FQ3 2025 (Sep 2025) | 2.09 | 2.09 | 0.895937B | -12.7% | 895.94M |
FQ4 2031 (Dec 2031) | 3.71 | 3.71 | 1.09984B | 100% | 1099.84M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.5898 | -- | 3.54081 | 3.66054 | 3 |
FQ3 2027 (Sep 2027) | 3.2127 | -- | 3.14502 | 3.2828 | 6 |
FQ2 2027 (Jun 2027) | 2.6453 | -- | 2.58957 | 2.70302 | 3 |
FQ1 2027 (Mar 2027) | 2.6893 | -- | 2.63264 | 2.74798 | 6 |
FQ4 2026 (Dec 2026) | 3.08836 | -- | 3.04621 | 3.14922 | 3 |
FQ3 2026 (Sep 2026) | 3.44865 | 39.4 | 3.36023 | 3.5278 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.22B | -- | 1.21B | 1.24B | 4 |
FQ3 2027 (Sep 2027) | 1.16B | -- | 1.14B | 1.18B | 5 |
FQ2 2027 (Jun 2027) | 1.09B | -- | 1.07B | 1.11B | 6 |
FQ1 2027 (Mar 2027) | 1.09B | -- | 1.08B | 1.11B | 3 |
FQ4 2026 (Dec 2026) | 1.11B | -- | 1.1B | 1.12B | 3 |
FQ3 2026 (Sep 2026) | 1.18B | 24.34 | 1.16B | 1.21B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -4.18 | -4.18 | 100% | |
FQ3 2024 (Sep 2024) | 1.34 | 1.34 | 100% | |
FQ2 2024 (Jun 2024) | 1.75 | 1.75 | 100% | |
FQ1 2024 (Mar 2024) | 1.45 | 1.45 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Jul 2023) | 1.89 | 1.89 | 100% | |
FQ3 2025 (Sep 2025) | 2.09 | 2.09 | 100% | |
FQ4 2031 (Dec 2031) | 3.71 | 3.71 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $1B | $1002.55M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.01B | $1009.76M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.03B | $1026.12M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.01B | $1011.56M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.01B | $1013.48M | 100% |
FQ3 2023 (Jul 2023) | $0B | $1.06B | $1059.94M | 100% |
FQ3 2025 (Sep 2025) | $0B | $0.9B | $895.94M | 100% |
FQ4 2031 (Dec 2031) | $0B | $1.1B | $1099.84M | 100% |